Emergency department decision aid for buprenorphine
Part of Mental health clinical trials.
This trial is testing a tool to help people in the emergency department decide whether to start buprenorphine (a medication for opioid use disorder). It's for patients who are not already on medication for their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with moderate to severe opioid use disorder.
- You speak and read English.
- You are not currently taking medication for opioid use disorder.
- You can use video calls and email after you leave the emergency department.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to help people in the emergency department who have moderate to severe opioid use disorder. It looks at using a decision-support tool to guide treatment choices.
This Phase 3 study tests whether starting a high dose of buprenorphine in the emergency department helps people with opioid use disorder come through withdrawal more safely and effectively. It focuses on people whose urine test shows fentanyl and who are already in withdrawal when they arrive.
This Phase 4 study tests an “emergency opioid engagement system” that aims to help people who are opioid-dependent start stopping opioid use. If you’re willing to stop and can safely participate, the program may offer structured support when you’re in the emergency setting.
This study compares a higher dose of buprenorphine (a medicine that helps stop opioid cravings and withdrawal) to the usual dose, given in the emergency department. It aims to see if the higher dose works better to start treatment for opioid use disorder.
This study looks at offering buprenorphine through emergency medical services (EMS) to people having an opioid emergency. It aims to see if starting treatment in the field helps people get connected to long-term care.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.